Smart Rotational Metering Pump for Enhanced Insulin Infusion

A novel system integrating a rotational metering pump with advanced technologies such as AI, IoT, blockchain, and new materials to provide personalized, real-time insulin infusion management for diabetes patients.

The original patent's rotational metering pump, while effective, lacks the ability to adapt to individual patient needs and provide secure, data-driven insights. The new inventive concept addresses these limitations by incorporating synergistic technologies to create a more powerful, connected, and intelligent insulin infusion system.

The smart rotational metering pump system comprises a wearable patch, a rotational metering pump, and integrated AI-based predictive analytics, IoT-enabled sensors, blockchain-based secure data storage, and advanced materials such as graphene and nanotechnology. The AI module analyzes user data and adjusts insulin dosage in real-time, while the IoT sensors collect vital signs and other relevant data. The blockchain-based storage ensures secure, tamper-proof medical records. The graphene-based reservoir and nanotechnology-enabled cannula assembly enhance biocompatibility and reduce inflammation.

The integration of AI, IoT, blockchain, and new materials with the rotational metering pump creates a novel, non-obvious system that provides unprecedented personalized diabetes management. The inventive step lies in the synergistic combination of these technologies to create a more powerful, connected, and intelligent insulin infusion system.

Alternative embodiments may include different AI algorithms, IoT sensor configurations, or blockchain architectures. Variations may also involve integrating the smart rotational metering pump with other wearable devices, such as smartwatches or fitness trackers, to expand its functionality and user engagement.

The smart rotational metering pump has significant commercial potential in the diabetes management market, with potential applications in personalized medicine, telehealth, and medical device innovation. The target industries include pharmaceuticals, medical devices, and healthcare technology.